Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The soluble urokinase plasminogen activator receptor (suPAR) is the bioactive form of uPAR, a membrane-bound glycoprotein, and it is primarily expressed on the surface of immunologically active cells. Mirroring local inflammation and immune activation, suPAR has gained interest as a potential prognostic biomarker in several inflammatory diseases. Indeed, in many diseases, including cancer, diabetes, cardiovascular diseases, kidney diseases, and inflammatory disorders, higher suPAR concentrations have been associated with disease severity, disease relapse, and mortality. Our review describes and discusses the supporting literature concerning the promising role of suPAR as a biomarker in different autoimmune rheumatic and non-rheumatic diseases.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140982 | PMC |
| http://dx.doi.org/10.3390/jpm13040688 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Associations of Biomarkers of Kidney Tubule Health with Retinal Microvascular Signs: The Multi-Ethnic Study of Atherosclerosis (MESA).
Kidney360
September 2025
Division of Nephrology-Hypertension, Department of Medicine, University of California San Diego, San Diego California.
Background: CKD is strongly associated with cardiovascular disease (CVD), yet the etiology responsible for this link remains elusive. Novel blood and urine biomarkers reflecting kidney tubule dysfunction and injury may provide novel insights to mechanisms linking the kidney to CVD.
Methods: In 470 participants of the Multi-Ethnic Study of Atherosclerosis (MESA) without type 2 diabetes, CVD or CKD, we measured six plasma (kidney injury molecule-1 [KIM-1], monocyte chemoattractant protein-1 [MCP-1], soluble urokinase plasminogen activator receptor [suPAR], tumor necrosis factor receptor [TNFR] 1 and 2, and anti-chitinase-3-like protein 1 [YKL-40]) and six urinary (alpha 1 microglobulin [A-1M], epidermal growth factor [EGF], KIM-1, MCP-1, YKL-40 and uromodulin [UMOD]) kidney tubule health biomarkers.
Profibrinolytic Factors and Cancer Progression, Metastasis, and Survival.
Arterioscler Thromb Vasc Biol
September 2025
Division of Hematology, Department of Medicine, UNC Blood Research Center, University of North Carolina at Chapel Hill.
The primary role of the fibrinolytic system is to degrade fibrin clots. However, the fibrinolytic system is often activated in patients with cancer and may affect cancer progression, metastasis, and patient survival. Clinical studies have shown that elevated plasma levels of uPA (urokinase plasminogen activator) are associated with cancer progression in patients with prostate and cervical cancers, whereas high plasma levels of soluble uPAR (uPA receptor) are associated with progression and metastasis in prostate, breast, bladder, and colorectal cancers.
View Article and Find Full Text PDFEnhancing patient stratification methods for medication review during acute admissions.
Br J Clin Pharmacol
August 2025
Department of Clinical Research, Copenhagen University Hospital Amager and Hvidovre, Hvidovre, Denmark.
Medication review in the hospital is an effective tool for identifying inappropriate prescribing, but not every patient can receive one due to resource constraints. Thus, it is important to identify patients who stand to benefit most from medication review. Patients are typically identified for medication review based on number of medications and age, but this may not be the most efficient strategy for identifying patients at high risk of future adverse clinical outcomes.
View Article and Find Full Text PDFBiomarkers of Inflammation and Their Association With the Severity and Onset of Preeclampsia: A Systematic Review.
Cureus
July 2025
Obstetrics and Gynaecology, Sultan Qaboos Hospital, Salalah, OMN.
Preeclampsia (PE) remains a leading cause of maternal and perinatal morbidity and mortality, with systemic inflammation playing a central role in its pathogenesis. Despite extensive research on inflammatory biomarkers, inconsistencies persist regarding their associations with disease severity and onset. This systematic review synthesizes current evidence on the relationship between inflammatory biomarkers and PE, focusing on their diagnostic and prognostic potential.
View Article and Find Full Text PDFSoluble Urokinase Plasminogen Activator Receptor (suPAR) Plasma Concentration Is Reduced Using Minimized Extracorporeal Circulation: Results of a Secondary Analysis of a Prospective Observational Study.
J Clin Med
July 2025
Department of Anesthesiology, Operative Intensive Care Medicine and Pain Therapy, University Hospital of Giessen and Marburg, Rudolf-Buchheim-Strasse 7, 35392 Giessen, Germany.
Minimized extracorporeal circulation (miECC) was developed to mitigate the adverse effects of cardiopulmonary bypass (CPB), yet its impact on soluble urokinase plasminogen activator receptor (suPAR) is unclear. SuPAR has been linked to adverse outcomes, including acute kidney injury (AKI). This study investigated perioperative suPAR kinetics in patients undergoing cardiac surgery with miECC or conventional CPB (cCPB) and explored its association with AKI, postoperative delirium (POD), and infections.
View Article and Find Full Text PDF